Workflow
Bristol Myers Squibb results top expectations as newer drugs help fuel growth
BMYBristol-Myers Squibb(BMY) Market Watch·2024-02-02 20:01

Bristol Myers Squibb Co. BMY, -0.41% on Friday reported fourth-quarter results that beat analysts’ expectations, helped by portfolio stalwarts like the blood thinner Eliquis as well as strong growth among newer drugs. The drugmaker reported fourth-quarter net income of 1.762billion,or87centspershare,downfrom1.762 billion, or 87 cents per share, down from 2.022 billion, or 95 cents per share, in the year-earlier period. Adjusted earnings per share came to 1.70,down71.70, down 7% from a year earlier but ahead of the FactSet consensus of 1.55. Revenue to ...